Armo amends IPO

Immuno-oncology company Armo BioSciences Inc. (Redwood City, Calif.) amended its proposed IPO on NASDAQ on Jan. 16 and now plans to sell 6.7 million shares at $14-$16. At the $15 midpoint, the compan...